LCN2 and cancer: Further digging detail into the clinic-pathological variable in the METABRIC cohort, our data explained that the LCN2 gene expression was higher for advanced cancer staging in the METABRIC cohort (Figure 4G and Table S1B), and the trend was observed in the TCGA cohort (Table S1B).